About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Seattle | 11,362 Studies Near You

Clinical TrialsSeattle

Clinical Trials in Seattle

Discover 11,362 clinical trials near Seattle, Washington. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2421-2440 of 11,362 trials

RecruitingProduct Surveillance RegistryThe purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products.NCT01524276·Birmingham, Alabama and 400 others

Find Trials by Condition in Seattle

Breast Cancerin Seattle Lung Cancerin Seattle Prostate Cancerin Seattle Colorectal Cancerin Seattle Melanomain Seattle Leukemiain Seattle Lymphomain Seattle Pancreatic Cancerin Seattle Ovarian Cancerin Seattle Brain Cancerin Seattle Diabetes

Data from ClinicalTrials.govTerms

TerminatedA Safety Study of SGN-2FF for Patients With Advanced Solid TumorsThis study is being done to find out the side effects (unwanted effects) that are caused in patients with cancers who are given SGN-2FF.NCT02952989·Birmingham, Alabama and 10 others

CompletedLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationRATIONALE: White blood cells from donors may be able to kill cancer cells in patients with cancer that has recurred following bone marrow or peripheral stem cell transplantation.NCT00003887·Seattle, Washington

Active not recruitingA Study of TAK-788 in Adults With Non-Small Cell Lung CancerThis study is about a medicine called TAK-788, also known as mobocertinib, given to adults with non-small cell lung cancer.NCT02716116·Birmingham, Alabama and 61 others

CompletedObservational Study of Convalescent Plasma for Treatment of Veterans With COVID-19The purpose of this study is to assess whether convalescent plasma therapy is associated with reduced 30-day all-cause mortality in a population of Veteran inpatients with…NCT04545047·Boston, Massachusetts and 1 other

TerminatedViral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell CarcinomaThis phase I/II trial studies the side effects and best way to give laboratory treated autologous T cells together with aldesleukin and to see how well it works in treating…NCT01758458·Seattle, Washington

RecruitingA Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)This trial will evaluate the efficacy and safety of various therapies in participants with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and untreated NSCLC tumors that…NCT04302025·Duarte, California and 37 others

CompletedStudy to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut AllergyThe purpose of this study is to determine etokimab safety, tolerability and activity in adult participants with peanut allergy.NCT02920021·Palo Alto, California and 1 other

CompletedA Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's DiseaseThe purpose of this study is to determine whether alpha-tocopherol, memantine (Namenda), or the combination will significantly delay clinical progression in mild to moderately…NCT00235716·Bay Pines, Florida and 13 others

TerminatedImpact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) ParticipantsThe primary objective of this study is to assess the effect of natalizumab compared to fingolimod on the evolution of new on-treatment T1-gadolinium-enhancing (Gd+) lesions to…NCT02342704·Aurora, Colorado and 41 others

CompletedA Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in RemissionThis is a first in human, prospective, multicenter, nonrandomized, open-label, dose-escalation study to investigate the safety, pharmacokinetics, pharmacodynamics and…NCT01632852·Chicago, Illinois and 4 others

CompletedStudy to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to PlaceboThe purpose of this study is to compare the safety and efficacy of generic Estradiol Vaginal Inserts, USP 10 mcg to the reference product Vagifem® 10 mcg and to determined whether…NCT01779947·Huntsville, Alabama and 24 others

CompletedSafety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's DiseaseThis study will evaluate the safety and efficacy of two different doses of Pasireotide in patients with de novo or recurrent/persistent Cushing's Disease.NCT00434148·Stanford, California and 67 others

TerminatedLong-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate CancerThis is a long-term prospective registry study to determine whether Prolaris testing in patients with favorable intermediate risk prostate cancer influences physician management…NCT03290508·Homewood, Alabama and 33 others

CompletedAccommodating for Residual Limb Fluid Volume ChangeThe purpose of this study is to quantify residual limb fluid volume changes between morning and afternoon hours, and to determine if fluid volume change is correlated with…NCT02124876·Seattle, Washington

CompletedPATH Partnering to Achieve Tobacco-free HealthThe overall aim of this 5-year project is to capitalize on the strong theoretical and promising empirical evidence for Acceptance \& Commitment Therapy (ACT) as an intervention…NCT01533974·Seattle, Washington

Active not recruitingA Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)This is an open-label, multicenter, non-randomized extension and long-term observational study.NCT03148418·Scottsdale, Arizona and 169 others

CompletedTo Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.Substudy A: The study will evaluate the safety, tolerability, and efficacy of a booster dose of BNT162b2 when administered to participants having previously received 2 doses of…NCT04955626·Athens, Alabama and 153 others

CompletedA Study of Nevirapine to Prevent HIV Transmission From Mothers to Their InfantsThe purpose of this study is to see if giving the anti-HIV drug nevirapine (NVP) to HIV-positive pregnant women and their infants can help reduce the chance that a mother will…NCT00001135·Birmingham, Alabama and 19 others

Active not recruitingModified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell LymphomaThis phase II trial investigates how well modified VR-CAP (bortezomib, rituximab, cyclophosphamide, doxorubicin hydrochloride, prednisone, and cytarabine hydrochloride) and…NCT04626791·New York, New York and 2 others

PreviousPage 122 of 569Next

in Seattle

Heart Diseasein Seattle